Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Inari Medical, Inc. (NARI) Q4 2022 Earnings Call Transcript
08:32pm, Monday, 27'th Feb 2023
Inari Medical, Inc. (NASDAQ:NARI ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Caroline Corner - IR Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - Chie
Inari Medical, Inc. (NARI) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Monday, 27'th Feb 2023
Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 35.29% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Inari Medical (NARI) Stock Now
08:17am, Friday, 17'th Feb 2023
Inari Medical (NARI) continues benefiting from its commitment to understand the venous system. However, dependency on the wide adoption of products is a concern.
Inari Medical, Inc. (NARI) Soars 6.3%: Is Further Upside Left in the Stock?
07:32am, Thursday, 16'th Feb 2023
Inari Medical, Inc. (NARI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price in
Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
04:01pm, Tuesday, 07'th Feb 2023
IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical (NARI) Reports Solid Preliminary Q4 Revenues
01:33pm, Thursday, 12'th Jan 2023
Inari Medical's (NARI) revenue growth in the fourth quarter is likely to have been boosted by continued demand for its products, market expansion and new launches.
Strength Seen in Inari Medical, Inc. (NARI): Can Its 5.6% Jump Turn into More Strength?
08:17am, Wednesday, 11'th Jan 2023
Inari Medical, Inc. (NARI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
05:17am, Saturday, 07'th Jan 2023
These companies are reporting financial results that aren't being reflected in their stock market performances.
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 21'st Dec 2022
IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients
Inari Medical: Retain Buy, No Change To Targets Despite Flat Price Action
05:52am, Tuesday, 29'th Nov 2022
Management raised FY22 revenue guidance to $373–$375mm, from a previous $360-$370mm. This followed a strong quarter with procedural growth across the portfolio.
Inari Medical (NARI) Q3 Earnings Beat, Revenues Rise Y/Y
12:48pm, Thursday, 03'rd Nov 2022
Inari Medical's (NARI) third-quarter results benefit from significant progress made across all its growth drivers.
Inari Medical, Inc. (NARI) Q3 2022 Earnings Call Transcript
11:38pm, Wednesday, 02'nd Nov 2022
Inari Medical, Inc. (NASDAQ:NARI ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Caroline Corner – Investor Relations Bill Hoffman – President and Chief Executi
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 20.83% and 6.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Inari Medical to Announce Third Quarter 2022 Financial Results
04:01pm, Thursday, 06'th Oct 2022
IRVINE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients
Here's Why You Should Retain Inari Medical (NARI) Stock Now
02:18pm, Thursday, 06'th Oct 2022
Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, dependency on the wide adoption of products is a woe.
